科研团队

当前位置: 首页 >> 科研团队 >> 细胞增殖和分化稳态 >> 正文

黄赞教授

学科专业

生物化学与分子生物学

研究方向

巨核细胞生成与核内有丝分裂;白血病与肝癌发生

实验室位置

生科院5020、5131室

联系电话

Email

z-huang@whu.edu.cn

教育经历/Education:

武汉大学 学士/ Wuhan University Bachelor

武汉大学 硕士/Wuhan University Master

芝加哥洛约拉大学 博士/Loyola University Chicago, PhD

美国芝加哥大学肿瘤研究所 博士后/ University of Chicago Ben May Institute for Cancer Research Post-doctoral Fellow

美国西北大学医学院 博士后/Northwestern University Feinberg School of Medicine Post-doctoral Fellow


主要工作经历和任职情况/Professional experience:

上海市儿童医院 研究助理/Children’s Hospital of Shanghai Research Associate

Loyola University Chicago 研究助理/Research Associate

武汉大学生命科学学院 教授/ Wuhan University College of Life Sciences Professor


主要社会兼职/Professional Affiliation:

美国血液学学会/American Society of Hematology

亚太医学生物免疫学会基础免疫学分会委员

湖北省医学生物免疫学会血液学分会学术委员会副主任

中国细胞生物学学会/Chinese Society for Cell Biology

中国生理学学会/Chinese Association for Physiological Sciences


主持课题项目/Funding

  1. 国自然青年科学基金项目(项目编号:30700412;2008-2010;主持)

  2. 国自然面上项目(编号:81070406;2011-2013;主持)

  3. 国自然面上项目(编号:31371481;2014-2017;主持)

  4. 国自然面上项目(编号:81670140;2018-2021;主持)

  5. 国自然面上项目(编号:81870427;2019-2022;主持)

  6. 国自然重大研究计划(培育)(编号:91957109;2020-2022;主持)

  7. 国自然面上项目(编号:32270643;2023-2026;主持)

  8. 教育部博士点基金(编号:20110141110016;2012-2014;主持)

  9. 教育部回国留学人员启动基金(2012;主持)

  10. 教育部“新世纪优秀人才支持计划”(编号:NCET-12-0422;2013-2015;主持)


发表论文#并列第一作者*通讯作者)/Selected Publications

  1. Jiaqi Sun, Xiyang Wang, Qingsong Shen, Min Wang, Shuxian Chen, Xuechun Zhang, Yongping Huang, Zhonglin Zhang, Wenhua Li, Yufeng Yuan;, Zan Huang; DNASE1L3 inhibits hepatocellular carcinoma by delaying cell cycle progression through CDK2. Cellular Oncology, Accepted

  2. Hu, Yufeng#; He, Wenzhi#; Huang, Yongping#; Xiang, Hui; Guo, Juan; Che, Yan; Cheng, Xu; Hu, Fengjiao; Hu, Manli; Ma, Tengfei; Yu, Jie; Tian, Han; Tian, Song; Ji, Yan-Xiao; Zhang, Peng; She, Zhi-Gang; Zhang, Xiao-Jing; Huang, Zan*; Yang, Juan*; Li, Hongliang*; Fatty Acid Synthase-Suppressor Screening Identifies Sorting Nexin 8 as a Therapeutic Target for NAFLD. Hepatology, 2021, 74(5): 2508-2525.

  3. Yan, Zhen-Zhen#; Huang, Yong-Ping#; Wang, Xin#; Wang, Hai-Ping; Ren, Fei; Tian, Rui-Feng; Cheng, Xu; Cai, Jie; Zhang, Yan; Zhu, Xue-Yong; She, Zhi-Gang; Zhang, Xiao-Jing; Huang, Zan*; Li, Hongliang*; Integrated Omics Reveals Tollip as an Regulator and Therapeutic Target for Hepatic Ischemia-Reperfusion Injury in Mice., Hepatology, 2019, 70(5): 1750-1769.

  4. Yang, Xuejing#; Lu, Bin#; Sun, Xueqin#; Han, Cuijuan; Fu, Chunling; Xu, Kailin; Wang, Min; Li, Dengju; Chen, Zhichao; Opal, Puneet; Wen, Qiang; Crispino, John D; Wang, Qian-Fei*; Huang, Zan*; ANP32A regulates histone H3 acetylation and promotes leukemogenesis. Leukemia, 2018, 32(7): 1587-1597.

  5. Ji YX#, Huang Z#, Yang X#, Wang X#, Zhao LP, Wang PX, Zhang XJ, Alves-Bezerra M, Cai L, Zhang P, Lu YX, Bai L, Gao MM, Zhao H, Tian S, Wang Y, Huang ZX, Zhu XY, Zhang Y, Gong J, She ZG, Li F, Cohen DE & Li H. The deubiquitinating enzyme cylindromatosis mitigates nonalcoholic steatohepatitis. Nat Med. 2018.

  6. Yan FJ, Zhang XJ, Wang WX, Ji YX, Wang PX, Yang Y, Gong J, Shen LJ, Zhu XY, Huang Z* & Li H*. The E3 ligase tripartite motif 8 targets TAK1 to promote insulin resistance and steatohepatitis. Hepatology. 2017;65(5):1492-1511.

  7. Wang X, Mao W, Fang C, Tian S, Zhu X, Yang L, Huang Z* & Li H*. Dusp14 protects against hepatic ischaemia-reperfusion injury via Tak1 suppression. J Hepatol. 2017.

  8. Lu B, Ren Y, Sun X, Han C, Wang H, Chen Y, Peng Q, Cheng Y, Cheng X, Zhu Q, Li W, Li HL, Du HN, Zhong B*, Huang Z*. Induction of INKIT by Viral Infection Negatively Regulates Antiviral Responses through Inhibiting Phosphorylation of p65 and IRF3. Cell Host Microbe. 2017;22(1):86-98 e84.

  9. Yan FJ, Zhang XJ, Wang WX, Ji YX, Wang PX, Yang Y, Gong J, Shen LJ, Zhu XY, Huang Z*, Li H*. The E3 ligase tripartite motif 8 targets TAK1 to promote insulin resistance and steatohepatitis. Hepatology. 2017;65(5):1492-1511.

  10. Jin Q, Ren Y, Wang M, Suraneni PK, Li D, Crispino JD, Fan J*, Huang Z*. Novel function of FAXDC2 in megakaryopoiesis. Blood Cancer J. 2016;6(9):e478.

  11. Lu B, Sun X, Chen Y, Jin Q, Liang Q, Liu S, Li Y, Zhou Y, Li W, Huang Z*. Novel function of PITH domain-containing 1 as an activator of internal ribosomal entry site to enhance RUNX1 expression and promote megakaryocyte differentiation. Cellular and Molecular Life Sciences: CMLS. 2015. 72(4): 821-832

  12. Lin Y, Li D, Liang Q, Liu S, Zuo X, Li L, Sun X, Li W, Guo M*, Huang Z*. miR-638 Regulates Differentiation and Proliferation in Leukemic Cells by Targeting Cyclin-dependent Kinase 2. J Biol Chem. 2015. 290(3): 1818-1828

  13. Sun X, Lu B, Hu B, Xiao W, Li W, Huang Z#. Novel function of the chromosome 7 open reading frame 41 gene to promote leukemic megakaryocyte differentiation by modulating TPA-induced signaling. Blood Cancer J.2014. 4: e198

  14. Liu L, Wen Q, Gong R, Gilles L, Stankiewicz MJ, Li W, Guo M, Li L, Sun X, Crispino JD, Huang Z*. PSTPIP2 dysregulation contributes to aberrant terminal differentiation in GATA-1-deficient megakaryocytes by activating LYN. Cell Death & Disease. 2014. 5: e988

  15. Wang W, Cai J, Wu Y, Hu L, Chen Z, Hu J, Li W, Guo M*, Huang Z*. Novel activity of KRAB domain that functions to reinforce nuclear localization of KRAB-containing zinc finger proteins by interacting with KAP1. Cellular and Molecular Life Sciences: CMLS.2013. 70(20): 3947-3958

  16. Khan I#, Huang Z#, Wen Q, Stankiewicz MJ, Gilles L, Goldenson B, Schultz R, Diebold L, Gurbuxani S, Finke CM, Lasho TL, Koppikar P, Pardanani A, Stein B, Altman JK, Levine RL, Tefferi A, Crispino JD. AKT is a therapeutic target in myeloproliferative neoplasms. Leukemia.2013. 27(9): 1882-1890

  17. Wen Q, Goldenson B, Silver SJ, Schenone M, Dancik V, Huang Z, Wang LZ, Lewis TA, An WF, Li X, Bray MA, Thiollier C, Diebold L, Gilles L, Vokes MS, Moore CB, Bliss-Moreau M, Verplank L, Tolliday NJ, Mishra R, Vemula S, Shi J, Wei L, Kapur R, Lopez CK, Gerby B, Ballerini P, Pflumio F, Gilliland DG, Goldberg L, Birger Y, Izraeli S, Gamis AS, Smith FO, Woods WG, Taub J, Scherer CA, Bradner JE, Goh BC, Mercher T, Carpenter AE, Gould RJ, Clemons PA, Carr SA, Root DE, Schreiber SL, Stern AM, Crispino JD. Identification of Regulators of Polyploidization Presents Therapeutic Targets for Treatment of AMKL. Cell.2012. 150(3): 575-589

  18. Wang W, Guo M, Hu L, Cai J, Zeng Y, Luo J, Shu Z, Li W*, Huang Z*. The zinc finger protein ZNF268 is overexpressed in human cervical cancer and contributes to tumorigenesis via enhancing NF-kappaB signaling. J Biol Chem.2012. 287(51): 42856-42866

  19. Huang Z, Dore LC, Li Z, Orkin SH, Feng G, Lin S, Crispino JD. GATA-2 reinforces megakaryocyte development in the absence of GATA-1. Mol Cell Biol. 2009;29(18):5168-5180.

  20. Huang Z, Richmond TD, Muntean AG, Barber DL, Weiss MJ, Crispino JD. STAT1 promotes megakaryopoiesis downstream of GATA-1 in mice. J Clin Invest. 2007;117(12):3890-3899.


专利/Patent

  1. Dimethyl fasudil for inducing polyploidization of megakaryocytes and for treating blood and bone marrow diseases and disorders. John D. Crispino; Qiang Wen; Zan Huang; Andrew M. Stern; Robert J. Gould. 2015-1-13, 美国, 8933071

  2. miR-638在抗急性髓系白血病中的应用;李文鑫、郭明雄、黄赞、林义; 2016-9-28, 中国, CN104208723A

  3. 用于制备肝癌检测试剂的新型代谢标志物及其应用;黄赞、孙佳琪;2022.07.29,中国,CN114814001A

  4. 用于制备治疗肝癌药物的新型代谢标志物及其应用;黄赞、孙佳琪;2022.07.29,中国,CN114807289A

  5. 用于制备治疗肝癌药物的代谢物及其应用;黄赞、孙佳琪;2022.05.24,中国,CN114522158A

  6. 靶向ANP32A抗白血病的小分子肽及其制备方法和应用;黄赞、王曼曼、张昙;2021.09.03,中国,CN113336829A

职称 教授 学科专业 生物化学与分子生物学
研究方向 巨核细胞生成与核内有丝分裂;白血病与肝癌发生 实验室位置 生科院5020、5131室
联系电话 Email z-huang@whu.edu.cn